• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: January 12-16, 2009

 

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Andrew von Eschenbach, Commissioner, Food and Drugs1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Frank Torti, Principal Deputy Commissioner and Chief Scientist, Food and Drugs1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
John Dyer, Deputy Commissioner for Operations and Chief Operating Officer1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Murray Lumpkin, Deputy Commissioner for International and Special Programs1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Randall Lutter, Deputy Commissioner for Policy1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Janet Woodcock, Director, Center for Drug Evaluation and Research1/13/09Washington, DCMurray Lumpkin, MD, Timothy Cole, Charles Grudzinskas, PhDMichael Vivion, PhD,, Frank Sasinowski, JD, Xavier Luria, MDAmerican Course on Drug Development and Regulatory Sciences - speech
Janet Woodcock, Director, Center for Drug Evaluation and Research1/14/09Washington, DCN/AN/AAPCO - Speech
Janet Woodcock, Director, Center for Drug Evaluation and Research1/15/09Bethesda, MDn/aBarbara Mittleman, NIHPublic-Privat Partnerships - Presentation
Michael Chappell, Acting Associate Commissioner, Office of Regulatory Affairs1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Jesse Goodman, Director, Center for Biologics Evaluation and Research1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Daniel Schultz, Director, Center for Devices and Radiological Health1/12/09 through 1/16/09N/AN/AN/ANo significant meetings
Stephen Sundlof, Center for Food Safety and Applied Nutrition1/13/2009College Park, MDBarbara Schneeman, Mary Poos, Bill Frankos, Dan Levy, Robert  Moore,  Nancy Yanish Linda Suydam, Consumer Healthcare Products Association (CHPA), Barbara Kochanowski, Marcia Howard, Steve Mister, Council for Responsible Nutrition, (CRN), Andrew Shao, Daniel Fabricant, American Herbal Products Association, (AHPA), Anthony Young, Katia Fowler, Dan Keravich, GlaxoSmithKline, GSK,  Ranga Velagaleti, BASF, Elizabeth Zafonte, Wyeth Consumer Health (WCH), Nathaniel Asamere, Brad Johnson (Proctor and Gamble), Elinor Hitchner, (Bayer Healthcare) FDA/ Industry Education Seminar Series on Dietary Supplements 
Stephen Sundlof, Center for Food Safety and Applied Nutrition1/14/2009College Park, MDSteve Musser, Dianne Benjamin, Latonia Parham (via phone) Mick Lovesrove, Director, McKinsey & Company, Matt Smith, Deep ShenoyUpdate on all  BPI  Workstreams.
Bernadette Dunham, Director, Center for Veterinary Medicine1/14/09Rockville, MDTracey Forfa, William Flynn, Roxanne SchweitzerLinda Duple, Bob Hinkley, Stephanie Batliner, Jennifer Spokes, Bill Zollers, Donna Fraunberger, Herschel Gaddy, Jeannie Smith, Gerald Macedo, Dominique Thibaud, Alicia Henk (Generic Animal Drug Alliance Members)Generic Animal Drug Alliance Update
William Slikker, Director, National Center for Toxicological Research1/16/09Jefferson, ARJohn Senior, Donna Mendrick, James Fuscoe, Rick Beger, Dan Buzatu, Weida Tong, Jon Wilkes, Li-Rong Yu, Lei GuoYvonne Dragan (AstraZeneca), Michael Lawton (Pfizer), Donald Mattison (NIH), Robert Roth (Michigan State University), Paul Watkins (University of North Carolina, Chapel Hill) and by phone - Neil Kaplowitz (Keck School of Medicine, University of Southern California)First meeting of the Hepatotoxicology Working Group
Gerald Masoudi, Chief Counsel1/12/09 through 1/16/09N/AN/AN/ANo significant meetings